Moderate riskFDA DeviceClass II

Remel Campy CVA Medium recalled for low Campylobacter recovery in culture

Remel's Campy CVA Medium (lot R01272, UDI 848838001055) is not reliably recovering Campylobacter Jejuni bacteria during laboratory culture testing. Customers reported low to no bacterial growth on this specific lot, which could lead to missed or delayed diagnoses.

From the FDA notice · Read the official notice ↗ · All Remel recalls

What to do

  1. Stop using lot R01272 (expires January 12, 2026) immediately
  2. Do not use UDI 848838001055 for any Campylobacter culture work
  3. Contact Remel or your supplier for replacement medium or instructions
  4. Review any culture results from this lot and consider retesting patient samples if clinically relevant

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Campy CVA Medium 100/PK, R01272
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
97
Illnesses reported
None reported
Manufactured in
12076 Santa Fe Trail Dr, N/A, Lenexa, KS, United States
Classification
Class II
Recall number
Z-1474-2026

In the FDA's words

Description
Campy CVA Medium 100/PK, R01272 Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium. UDI-DI 848838001055 Lot R01272 lot 339135 Expired January 12, 2026 Distribution: US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA. Affected quantity: 97
Hazard
Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

More from Remel

See all

Related topics